´
A. Szczepanska et al. / Tetrahedron 59 (2003) 4775–4783
4782
Anal. calcd for 9a (C16H28N4O9): C, 45.71; H, 6.71; N,
13.33. Found: C, 45.61; H, 6.81; N, 13.24.
gave 10b as a white solid in 22% yield. Mp 138–1408C;
[a]2D0¼28.0 (c 0.5, MeOH); 1H NMR (400 MHz, CDCl3) d
3.25–3.52 (m, 4H; 2£NHCH2), 3.52–3.65 (m, 8H;
4£CH2O), 3.65–3.74 (dt, 4H, J1¼4.6 Hz, J2¼3.8 Hz;
2£NHCH2CH2O), 3.74–3.87 (m, 4H; 2£CH2O), 3.87–
4.04 (m, 4H; 2£CHCH2), 4.08 (ddAB, 4H, JAB1¼15.6 Hz,
JAB2¼15.7 Hz; 2£COCH2), 4.20–4.36 (m, 2H; 2£OH),
4.55–4.67 (m, 2H; 2£CHCH2), 7.43 (t, 2H, J¼5.5 Hz;
2£CONHCH2), 7.81 (dd, 2H, J1¼8.1 Hz, J2¼7.9 Hz;
2£CHNHCO); 13C NMR (100 MHz, CDCl3) d 39.2, 39.3,
54.4, 62.6, 62.7, 69.3, 69.4, 70.1, 70.2, 70.4, 70.5, 70.6,
70.6, 70.7, 70.8, 170.5, 170.6, 170.7, 170.8; IR (KBr):
n¼3423, 3095, 2928, 1657, 1541, 1466, 1350 cm21; HRMS
(LSIMS) calcd for C20H36N4O11Na [MþNa]þ: 531.2278.
Found 531.2280.
4.4.8. (2S,15S)-1,4,13,16-Tetraaza-2,15-dihydroxy-
methyl-7,10,19,22-tetraoxa-3,14,17,24-cyclotetraeicosa-
tetraone, 9b. Compound 9b was prepared using the diamine
4b and dimethyl ester 3e. Purification by silica gel column
chromatography using CH2Cl2 and MeOH (95:5) gave 9b as
a white solid in 27% yield. Mp 123–1248C; [a]2D0¼211.7 (c
1.0, MeOH); 1H NMR (200 MHz, CDCl3) d 3.10–3.85 (bm,
22H; 2£OCH2, 2£NHCH2CH2OCH2, 2£CH2OH), 4.08
(dAB, 4H, JAB¼16.0 Hz; 2£COCH2), 4.40–4.65 (m, 2H;
2£CHCH2), 7.21 (bs, 2H; 2£CONHCH2), 7.90 (d, 2H,
J¼7.9 Hz; 2£CHNHCO); 13C NMR (50 MHz, CDCl3) d
39.4, 55.3, 63.2, 69.7, 70.4, 71.2, 71.4, 171.1, 171.4; IR
(KBr): n¼3378, 3299, 3101, 2932, 2891, 1652, 1531, 1470,
1437, 1338 cm21
;
HRMS (LSIMS) calcd for
4.4.12. (2S,18S)-1,4,16,19-Tetraaza-2,18-dihydroxy-
methyl-7,10,13,22,25,28-hexaoxa-3,17,20,30-cyclotri-
acontatetraone, 10c. Compound 10c was prepared using
the diamine 4c and dimethyl ester 3f. Purification by silica
gel column chromatography using CH2Cl2 and MeOH
(95:5) gave 10c as a colorless oil in 12% yield. [a]2D0¼21.1
(c 1.0, EtOH); 1H NMR (500 MHz, CDCl3) d 3.25–3.85 (m,
26H; 10£CH2O, 2£NHCH2, 2£OH), 4.07 (dAB, 4H,
C18H32N4O10Na [MþNa]þ: 487.2016. Found 487.2008.
Anal. calcd for 9b (C18H32N4O10): C, 46.55; H, 6.94; N,
12.06. Found: C, 46.36; H, 7.00; N, 11.80.
4.4.9. (2S,18S)-1,4,16,19-Tetraaza-2,18-dihydroxy-
methyl-7,10,13,22,25-pentaoxa-3,17,20,27-cycloheptaei-
cosatetraone, 9c. Compound 9c was prepared using the
diamine 4c and dimethyl ester 3e. Purification by silica gel
column chromatography using CH2Cl2 and MeOH (95:5)
gave 9c as a white solid in 20% yield. Mp 127–1298C;
JAB¼15.6 Hz;
2£COCH2),
3.93–4.10
(m,
4H;
2£CHCH2), 4.50–4.61 (m, 2H; 2£CHCH2), 7.26 (bs, 2H;
2£CH2NHCO), 7.80 (d, 2H, J¼7.8 Hz; 2£CHNHCO); 13C
NMR (125 MHz, CDCl3) d 39.2, 54.6, 62.9, 69.5, 70.0,
70.6, 70.9, 71.0, 71.1, 170.5, 170.7; IR (CHCl3): n¼3676,
3397, 2918, 2880, 1745, 1667, 1526, 1456, 1439,
1348 cm21; HRMS (LSIMS) calcd for C22H40N4O12Na
[MþNa]þ: 575.2540. Found 575.2548.
[a]2D0¼22.6 (c 1.0, EtOH); H NMR (400 MHz, CDCl3) d
1
3.33–3.52 (m, 4H; 2£NHCH2), 3.54–3.80 (m, 18H;
8£CH2O, 2£OH), 3.82–4.02 (m, 4H; 2£CHCH2), 4.10
(dd, 4H, J1¼15.8 Hz, J2¼15.0 Hz; 2£COCH2), 4.49–4.58
(m, 2H; 2£CHCH2), 7.11 (bt, 1H, J¼5.4 Hz; CH2NHCO),
7.30 (bt, 1H, J¼5.2 Hz; CH2NHCO), 7.72 (d, 1H,
J¼7.9 Hz; CHNHCO), 7.80 (d, 1H, J¼8.1 Hz; CHNHCO);
13C NMR (100 MHz, CDCl3) d 39.0, 39.3, 54.5, 54.8, 62.7,
62.8, 69.1, 69.2, 69.7, 69.9, 70.4, 70.6, 70.7, 70.8, 70.9,
71.2, 170.3, 170.4, 170.6, 170.7; IR (CHCl3): n¼3693,
3396, 2931, 2878, 1743, 1674, 1603, 1520, 1456, 1436,
1348 cm21; HRMS (LSIMS) calcd for C20H36N4O11Na
[MþNa]þ: 531.2278. Found 531.2263.
4.4.13. (2S)-1,4,10-Triaza-2-methyl-7,13-dioxa-3,11,15-
cyclopentadecatrione,11. Compound 11 was obtained as
a white solid in 13% yield. Mp 135–1408C; [a]2D0¼226.1 (c
1
1.0, MeOH); H NMR (200 MHz, CDCl3) d 1.41 (d, 3H,
J¼7.1 Hz; CH3), 3.10–3.29 (m, 1H; NHCHH), 3.40–3.62
(m, 6H; CH2CH2OCH2), 3.63–3.82 (m, 1H; NHCHH), 4.10
(ddAB, 4H, JAB1¼15.7 Hz, JAB2¼14.8 Hz; 2£COCH2), 4.64
(m, 1H; CHCH3), 6.81 (bs, 1H; CH2NHCO), 7.01 (d, 1H,
J¼7.9 Hz; CHNHCO), 7.17 (bs, 1H; CH2NHCO); 13C
NMR (50 MHz, CDCl3) d 17.0, 39.0, 39.6, 48.9, 69.6, 70.0,
71.3, 71.4, 169.2, 169.4, 172.0; IR (CHCl3): n¼3689, 3607,
3441, 3413, 3013, 2932, 2873, 2806, 1681, 1603, 1532,
1456, 1436, 1382, 1346 cm21; HRMS (LSIMS) calcd for
C11H20N3O5 [MþH]þ: 274.1403. Found 274.1417.
4.4.10. (2S,12S)-1,4,10,13-Tetraaza-2,12-dihydroxy-
methyl-7,16,19,22-tetraoxa-3,11,14,24-cyclotetraeicosa-
tetraone, 10a. Compound 10a was prepared using the
diamine 4a and dimethyl ester 3f. Purification by silica gel
column chromatography using CH2Cl2 and MeOH (95:5)
gave 10a as a white solid in 22% yield. Mp 1578C;
1
[a]2D0¼28.9 (c 0.5, MeOH); H NMR (200 MHz, DMSO-
d6) d 3.10–3.33 (m, 4H; 2£NHCH2), 3.43 (bs, 4H; 2£CH2O),
3.67 (bs, 12H; 4£CH2O, 2£CHCH2), 4.01 (s, 4H; 2£COCH2),
4.33(dt, 2H, J1¼5.3 Hz, J2¼7.9 Hz; 2£CHCH2), 5.04(bt, 2H,
J¼5.3 Hz; 2£OH), 7.71 (d, 2H, J¼7.9 Hz; CHNHCO), 7.89
(bt, 2H, J¼5.2 Hz; 2£CONHCH2); 13C NMR (50 MHz,
DMSO-d6)d55.1, 61.7, 69.0, 69.9, 70.2, 70.6, 169.8,170.1;IR
(KBr): n¼3436, 3100, 2934, 2874, 1655, 1550, 1445,
1349 cm21; HRMS (LSIMS) calcd for C18H32N4O10Na
[MþNa]þ: 487.2016. Found 487.2040.
4.4.14. (2S)-1,4,13-Triaza-2-methyl-7,10,16-trioxa-3,14,
18-cyclooctadecatrione, 12. Compound 12 was obtained
as a white solid in 15% yield. Mp 68–698C; [a]2D0¼þ63.7 (c
1.0, MeOH); 1H NMR (200 MHz, CDCl3) d 1.41 (d, 3H, J¼
7.2 Hz; CH3), 3.10–3.82 (m, 12H; 6£CH2), 4.07 (ddAB, 4H;
JAB1¼15.2 Hz, JAB2¼14.5 Hz; 2£COCH2), 4.70 (m, 1H;
CHCH3), 6.82 (bm, 1H; CONHCH2), 7.27 (d, 1H, J¼
7.9 Hz; CHNHCO), 7.48 (bm, 1H; CONHCH2); 13C NMR
(50 MHz, CDCl3) d 18.4, 39.0, 39.8, 48.9, 70.3, 70.6, 70.8,
70.9, 71.0, 71.1, 168.6, 168.8, 172.0; IR (CHCl3): n¼3433,
2922, 1676, 1532, 1455, 1348 cm21; HRMS (LSIMS) calcd
for C13H23N3O6Na [MþNa]þ: 340.1485. Found 340.1494.
4.4.11. (2S,15S)-1,4,13,16-Tetraaza-2,15-dihydroxy-
methyl-7,10,19,22,25-pentaoxa-3,14,17,27-cycloheptaei-
cosatetraone, 10b. Compound 10b was prepared using the
diamine 4b and dimethyl ester 3f. Purification by silica gel
column chromatography using CH2Cl2 and MeOH (95:5)
4.4.15. (2S)-1,4,10-Triaza-2-hydroxymethyl-7,13-dioxa-
3,11,15-cyclopentadecatrione, 13. Compound 13 was